Author
The author is Chief Interventional Cardiologist and the Managing Director of Bankers Heart Institute and also serves as Honorary Professor of Cardiology at SSG Hospital & Medical College, Baroda
Capping the price of a device is counter-productive - it will halt research and innovation and won't benefit the patient; the cost of the device such as stent is a mere fraction of the total cost of the procedure required for its implantation
Read More
